AGIO
NASDAQ · Biotechnology
Agios Pharmaceuticals Inc
$27.79
+0.26 (+0.94%)
Open$27.50
Previous Close$27.53
Day High$28.21
Day Low$27.50
52W High$46.00
52W Low$22.24
Volume—
Avg Volume1.25M
Market Cap1.64B
P/E Ratio—
EPS$-7.12
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-60.9% upside
Current
$27.79
$27.79
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.17M | 35.37M | 198.27M |
| Net Income | -421,480,714 | -243,208,721 | -11,344,752 |
| Profit Margin | -764.0% | -725.8% | -5.7% |
| EBITDA | -474,796,213 | -289,194,333 | -15,767,673 |
| Free Cash Flow | — | — | -7,306,109 |
| Rev Growth | +56.0% | +56.0% | -2.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |